Senator Bernie Sanders just called out Ariad Pharmaceuticals over the price of its leukemia drug, and the company's stock is dropping fast.
Ariad, which makes a drug called Iclusig, has raised the price of the drug four times this year, The Street reports. It now costs $199,000 a year, before factoring in insurance or any discounts. The company's stock was down 10% Friday afternoon.
When it was first approved in 2012, the drug cost $9,580 a month. Now, it costs $16,560 a month, a 73% increase. Along the way, the drug has had some safety problems and actually got pulled off the market in 2013 by the FDA, but a few months later was reinstated with warnings about cardiovascular problems that may occur.
Tweet Embed:
https://twitter.com/mims/statuses/786969683698286596
Drug corporations' greed is unbelievable. Ariad has raised the price of a leukemia drug to almost $199,000 a year. https://t.co/EB4nEPxP2G
Here's what the stock looked like Friday afternoon.
NOW WATCH: FEMA is tracking Hurricane Matthew using the 'Waffle House Index'
See Also:
- These are the 20 best-selling books of 2016 so far
- A space station camera has recorded extremely detailed video of North Korea's capital city
- Illumina is crashing after giving investors terrible news about its revenue
SEE ALSO: Bill Gates: we’re witnessing 'one of the greatest success stories in the history of global health'
DON'T MISS: Zika has spread to another neighborhood in Miami
